Literature DB >> 25883790

Reevaluating the hype: four bacterial metabolites under scrutiny.

E E Fröhlich1, R Mayerhofer1, P Holzer1.   

Abstract

With microbiome research being a fiercely contested playground in science, new data are being published at tremendous pace. The review at hand serves to critically revise four microbial metabolites widely applied in research: butyric acid, flagellin, lipoteichoic acid, and propionic acid. All four metabolites are physiologically present in healthy humans. Nevertheless, all four are likewise involved in pathologies ranging from cancer to mental retardation. Their inflammatory potential is equally friend and foe. The authors systematically analyze positive and negative attributes of the aforementioned substances, indicating chances and dangers with the use of pre- and probiotic therapeutics. Furthermore, the widespread actions of microbial metabolites on distinct organs and diseases are reconciled. Moreover, the review serves as critical discourse on scientific methods commonly employed in microbiome research and comparability as well as reproducibility issues arising thereof.

Entities:  

Keywords:  butyric acid; flagellin; lipoteichoic acid; microbial metabolites; microbiota; propionic acid

Year:  2015        PMID: 25883790      PMCID: PMC4397844          DOI: 10.1556/EUJMI-D-14-00030

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  177 in total

1.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms.

Authors:  J Bienenstock; S Collins
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

2.  Impaired innate immunity in Crohn's disease.

Authors:  Mònica Comalada; Maikel P Peppelenbosch
Journal:  Trends Mol Med       Date:  2006-08-04       Impact factor: 11.951

3.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages.

Authors:  Luigi Franchi; Amal Amer; Mathilde Body-Malapel; Thirumala-Devi Kanneganti; Nesrin Ozören; Rajesh Jagirdar; Naohiro Inohara; Peter Vandenabeele; John Bertin; Anthony Coyle; Ethan P Grant; Gabriel Núñez
Journal:  Nat Immunol       Date:  2006-04-30       Impact factor: 25.606

4.  The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.

Authors:  Brian F Hinnebusch; Shufen Meng; James T Wu; Sonia Y Archer; Richard A Hodin
Journal:  J Nutr       Date:  2002-05       Impact factor: 4.798

5.  Overexpression of Bcl-2 regulates sodium butyrate- and/or docetaxel-induced apoptosis in human bladder cancer cells both in vitro and in vivo.

Authors:  H Miyake; S Hara; S Arakawa; S Kamidono; I Hara
Journal:  Int J Cancer       Date:  2001-07-01       Impact factor: 7.396

6.  Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

Authors:  Christine B Turley; Richard E Rupp; Casey Johnson; David N Taylor; Julie Wolfson; Lynda Tussey; Uma Kavita; Lawrence Stanberry; Alan Shaw
Journal:  Vaccine       Date:  2011-05-30       Impact factor: 3.641

7.  Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.

Authors:  Sophie Bourdu; Michel Dapoigny; Eric Chapuy; Fabrice Artigue; Marie-Paule Vasson; Pierre Dechelotte; Gilles Bommelaer; Alain Eschalier; Denis Ardid
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

8.  Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.

Authors:  A B Burlina; H Ogier; H Korall; F K Trefz
Journal:  Mol Genet Metab       Date:  2001-04       Impact factor: 4.797

9.  Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.

Authors:  L E M Willemsen; M A Koetsier; S J H van Deventer; E A F van Tol
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

10.  Production of a mixture of antimicrobial organic acids from lactose by co-culture of Bifidobacterium longum and Propionibacterium freudenreichii.

Authors:  M Taniguchi; H Nakazawa; O Takeda; T Kaneko; K Hoshino; T Tanaka
Journal:  Biosci Biotechnol Biochem       Date:  1998-08       Impact factor: 2.043

View more
  4 in total

Review 1.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

2.  Fecal Transplants: What Is Being Transferred?

Authors:  Diana P Bojanova; Seth R Bordenstein
Journal:  PLoS Biol       Date:  2016-07-12       Impact factor: 8.029

3.  Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines.

Authors:  R E Frye; S Rose; J Chacko; R Wynne; S C Bennuri; J C Slattery; M Tippett; L Delhey; S Melnyk; S G Kahler; D F MacFabe
Journal:  Transl Psychiatry       Date:  2016-10-25       Impact factor: 6.222

4.  Gut microbiome of Moroccan colorectal cancer patients.

Authors:  Imane Allali; Noureddine Boukhatem; Leila Bouguenouch; Hanaa Hardi; H Abir Boudouaya; M Belen Cadenas; Karim Ouldim; Saaïd Amzazi; M Andrea Azcarate-Peril; Hassan Ghazal
Journal:  Med Microbiol Immunol       Date:  2018-04-23       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.